Epidemiological and Clinical Risk Factors for Breast Cancer‐Related Lymphedema: A Case‐Control Study From Hamadan, Western Iran
BioMed Research International · 2026
DOI: 10.1155/bmri/8099570 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, 2026. Verfasst von Soulmaz Rahbar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiotherapy, School of Rehabilitation Sciences, Hamadan University of Medical Sciences, Hamadan, Iran, umsha.ac.ir. Hauptthemen laut MEDLINE: Breast Neoplasms, Breast Cancer Lymphedema. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamadan University of Medical Sciences.
Abstract (Originalsprache)
Background
Breast cancer‐related lymphedema (BCRL) is one of main issues following treatments in patients with breast cancer (BC). The current study is aimed at evaluating epidemiological and clinical risk factors for BCRL in female patients with BC.
Methods
In a case‐control study design from October 2024 to March 2025, female BC patients with and without BCRL were recruited from the Lymphedema Physiotherapy Clinic and the Cancer Therapeutic and Diagnosis Imaging Center in Hamadan, Western Iran. Patient, tumor, and treatment characteristics were gathered via interview and reviewing medical and pathology records.
Results
Overall, 230 patients (127 cases and 103 controls) were included. The multivariable analysis revealed several potential risk factors for BCRL: older age at diagnosis (odds ratio [OR] = 1.05; 95% confidence interval [CI], 1.00, 1.10), urban residency (4.76; 1.20, 20.00), axillary lymph node dissection number of 6–9 compared to ≤ 5 (2.54; 0.99, 6.49), pathology grade of 2 (7.11; 1.47, 34.27) and 3 (6.53; 1.32, 32.32) compared to Grade 1, mastectomy versus lumpectomy (2.86; 1.23, 6.67), receiving chemotherapy (9.55; 1.23, 73.95), and positive progesterone receptor (PR) status (2.56; 1.16, 5.55).
Conclusion
The combination of patient, tumor, and treatment characteristics may be associated with BCRL, highlighting the close monitoring of high‐risk patients (older age, high‐grade tumors, mastectomy, and PR‐positive) in Western Iran.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiotherapy, School of Rehabilitation Sciences, Hamadan University of Medical Sciences, Hamadan, Iran, umsha.ac.ir.
- Department of Physical Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran, mui.ac.ir.
- Department of Physiotherapy, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
- Cancer Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, Iran, umsha.ac.ir.
ORCID-Profile: Soulmaz Rahbar, Hojjat Radinmehr, Mohammad Reza Asadi, Tayebeh Roghani, Azade Tabatabaei, Abdolazim Sedighi Pashaki, Erfan Ayubi
Förderung
- Hamadan University of Medical Sciences
Zitieren
APA
Rahbar, S., Radinmehr, H., Asadi, M. R., Roghani, T., Tabatabaei, A., Sedighi Pashaki, A., & Ayubi, E. (2026). Epidemiological and Clinical Risk Factors for Breast Cancer‐Related Lymphedema: A Case‐Control Study From Hamadan, Western Iran. BioMed Research International. https://doi.org/10.1155/bmri/8099570
Vancouver
Rahbar S, Radinmehr H, Asadi MR, Roghani T, Tabatabaei A, Sedighi Pashaki A, et al. Epidemiological and Clinical Risk Factors for Breast Cancer‐Related Lymphedema: A Case‐Control Study From Hamadan, Western Iran. BioMed Research International. 2026. doi:10.1155/bmri/8099570
BibTeX
@article{Rahbar2026,
author = {Rahbar, Soulmaz and Radinmehr, Hojjat and Asadi, Mohammad Reza and Roghani, Tayebeh and Tabatabaei, Azade and Sedighi Pashaki, Abdolazim and Ayubi, Erfan},
title = {Epidemiological and Clinical Risk Factors for Breast Cancer‐Related Lymphedema: A Case‐Control Study From Hamadan, Western Iran},
journal = {BioMed Research International},
year = {2026},
doi = {10.1155/bmri/8099570}
}
EUVIMED